Navigation Links
Beta Blocker Use Questioned in Non-Heart Surgery
Date:11/10/2008

Increased risk of stroke a major issue in analysis of 33 research projects

MONDAY, Nov. 10 (HealthDay News) -- An analysis of 33 studies on drugs known as beta blockers has concluded that they are not useful in any surgical procedure other than heart surgery. In fact, using beta blockers for non-coronary surgery may actually increase the risk of stroke, the scientists say.

The researchers who conducted the study -- known as a meta-analysis -- recommend that the guidelines committees of both the American College of Cardiology and the American Heart Association "soften" their recommendations that beta blockers be used to prevent surgical complications in non-coronary operations.

"Our study says that if you look at the overall picture, do a meta-analysis, studies that are not particularly well-done come to the conclusion that they are useful," said Dr. Franz Messerli, professor of medicine at Columbia University and an author of a report published online by The Lancet to coincide with the annual heart meeting now underway. "But if you look at the high-quality studies, there are distinctly more strokes with beta blockers." Beta blockers are drugs that inhibit adrenaline and slow the nerve impulses to the heart. They can also be used to treat irregular heartbeat, known as arrhythmia.

The meta-analysis did show a 35 percent reduced risk of heart attacks and a 64 percent reduction in less serious heart artery blockages among the more than 12,000 participants in all the studies where beta blockers were prescribed before surgery. But there was no overall reduction in total deaths, heart failure or deaths due to heart disease, and a doubled risk of nonfatal stroke.

Beta blocker usage was also associated with a high risk of bradycardia, low heart rate requiring medical treatment, which occurred in 1 of every 22 people getting beta blockers, and of lower blood pressure dangerous enough to require treatment.'/>"/>

Copyright©2008 ScoutNews,LLC.
All rights reserved  

Page: 1 2 3

Related medicine news :

1. Questions Continue About Using Beta Blockers Before Surgery
2. Beta Blockers Help Hospitalized Heart Failure Patients
3. Beta Blocker May Shrink Infant Hemangiomas
4. Beta Blockers Raise Stroke, Death Risk After Surgery
5. Study Shows Increased Out-of-Pocket Expenses May Negatively Influence Initiation of TNF Blocker Therapy
6. Women are treated less frequently than men with statins, aspirin and beta-blockers
7. Venture Global Limited Introduces an Innovative Anti-Cellphone Radiation Sticker Named VEGO Power Blocker
8. Scripps scientists find calcium channel blockers help normalize lysosomal storage disease cells
9. FDA approves Bystolic, a novel beta blocker
10. Blood-vessel blocker aids cancer-killing virus
11. Beta Blocker Doesnt Help Children With Heart Failure
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Beta Blocker Use Questioned in Non-Heart Surgery
Beta Blocker Use Questioned in Non-Heart Surgery
(Date:7/2/2009)...rocessing Technology Institute (BTI) have made a n...inhibitory molecule" (FAIM), protects both immune ... death. , Their research is published in the cu... The scientists, Jianxin Huo, Ph.D., and Shengli ...ossibly be manipulated for clinical application an...
(Date:7/2/2009)...USNewswire/ -- Recent news reports have highlighte...ring that physicians meet high standards in their ... Board of Medical Specialties (ABMS), which coordi...forts to develop and implement educational and pro...cation of physician specialists. Certification by...
(Date:7/2/2009)...USNewswire/ -- Pro-life forces won an important ba...o uphold a state law regulating that abortion cent...tering RU-486 (also known as the "abortion pill") ...drug. , , The ruling came in Rogers v. Planne...o a 2004 law requiring that those administering RU...
(Date:7/2/2009)...esses honored in Washington, D.C. , , ARLINGTO...s Health Resources has received the Best Employer...Business Group on Health. , , (Logo: http://... ) , , The award recognizes the nation,s lead...ote a healthy workplace and for helping employees ...
Breaking Medicine News(10 mins):Health News:Gene's novel role may provide key to treating liver and neurodegenerative diseases 2Health News:Seek Out Credentials Before Choosing a Physician - Is Your Cardiologist Board Certified in Cardiovascular Disease? 2Health News:Seek Out Credentials Before Choosing a Physician - Is Your Cardiologist Board Certified in Cardiovascular Disease? 3Health News:Seek Out Credentials Before Choosing a Physician - Is Your Cardiologist Board Certified in Cardiovascular Disease? 4Health News:Ohio Supreme Court Strikes a Blow to Planned Parenthood in Upholding Regulation of 'Abortion Pill' 2Health News:Texas Health Resources Recognized by National Business Group on Health as Leading Employer Promoting Healthy Lifestyles for Employees 2Health News:Texas Health Resources Recognized by National Business Group on Health as Leading Employer Promoting Healthy Lifestyles for Employees 3
...d poisoning in children, The Medical Research Coun...ren’s homes with vivid colors, will do good// to r...evels of lead in paints. Earlier in the year, th...n tested, had portrayed toxic levels of lead in th...
...ly used for a number of painful complaints, have ...d stroke//. This has lead to an order by the Commi...have to carry a warning along with the information...Doctors are being informed of the small but increa...
...e with breast cancer has led to confusion among wo...st cancer//. Cancer Research UK said that most w...to strike the under-70s than women over 70,. Thei...d that 77 per cent of them thought that a woman's ...
...agnosed with polio in spite of receiving 9 doses o...ement, polio can be prevented by 4-10 doses of the...his girl called Jannat. “Earlier she used to roam...stand properly,” Jannat's Mother, Akhbari Khatun s...
Other Medicine News:
(Date:7/3/2009)...nd, July 3 BioCis Pharma Ltd., a p...eadquarters in Turku, Finland,announced positive...oCure(TM),emulsion cream, the company,s novel top...cebo-controlled study, conducted in Finland, inclu...atitis who applied the ProtoCure,emulsion cream t...
(Date:7/1/2009)...Denmark, July 1 A just p...n on Investigational Drugs", Volume,18, Issue 7 2...n,PROSTVAC(TM). This is the most comprehensive an... Quote from the article: "Preliminary clinical tri... II trials have suggested a survival benefit,afte...
(Date:6/30/2009)...30 Calixa Therapeutics Inc. today ...al of CXA-101 in patients with complicated urinary...m, parenteral cephalosporin antibiotic with excell...udomonas aeruginosa , including drug resistant iso...tial treatment for serious bacterial infections in...
(Date:6/29/2009)...ets for Novel Biotherapeutics Based On Naturally R...9 Pangu BioPharma, a subsidiary of...ing of its third patent application on proprietary...ases. Although tRNA synthetases are universal and...ry found in all organisms, human synthetases have ...
Breaking Medicine Technology:BioCis Pharma Reports Positive Phase IIa Clinical Results in Atopic Dermatitis 2New Review on PROSTVAC(TM) Published by Key Investigators From NCI 2Calixa Therapeutics Announces Initiation of Phase 2 Clinical Trial of Its Antibiotic, CXA-101, in Patients with Complicated Urinary Tract Infections 2Pangu BioPharma, aTyr Pharma's Subsidiary in Hong Kong, Files Three Patent Applications 2Pangu BioPharma, aTyr Pharma's Subsidiary in Hong Kong, Files Three Patent Applications 3Nanotechnologists gain powerful new materials probe 10675 1Nanotechnologists gain powerful new materials probe 10675 2ArvinMeritor Proud to Sponsor American Heart Association Campaign 37779 1ArvinMeritor Proud to Sponsor American Heart Association Campaign 37779 2AMICAS Reports Financial Results for the Fourth Fiscal Quarter and Year Ended December 31 2008 37774 1AMICAS Reports Financial Results for the Fourth Fiscal Quarter and Year Ended December 31 2008 37774 2AMICAS Reports Financial Results for the Fourth Fiscal Quarter and Year Ended December 31 2008 37774 3AMICAS Reports Financial Results for the Fourth Fiscal Quarter and Year Ended December 31 2008 37774 4AMICAS Reports Financial Results for the Fourth Fiscal Quarter and Year Ended December 31 2008 37774 5AMICAS Reports Financial Results for the Fourth Fiscal Quarter and Year Ended December 31 2008 37774 6AMICAS Reports Financial Results for the Fourth Fiscal Quarter and Year Ended December 31 2008 37774 7AMICAS Reports Financial Results for the Fourth Fiscal Quarter and Year Ended December 31 2008 37774 8AMICAS Reports Financial Results for the Fourth Fiscal Quarter and Year Ended December 31 2008 37774 9AMICAS Reports Financial Results for the Fourth Fiscal Quarter and Year Ended December 31 2008 37774 10AMICAS Reports Financial Results for the Fourth Fiscal Quarter and Year Ended December 31 2008 37774 11AMICAS Reports Financial Results for the Fourth Fiscal Quarter and Year Ended December 31 2008 37774 12AMICAS Reports Financial Results for the Fourth Fiscal Quarter and Year Ended December 31 2008 37774 13AMICAS Reports Financial Results for the Fourth Fiscal Quarter and Year Ended December 31 2008 37774 14VVA Introduces Collaboration Between Veterans and Private Sector to Address Healthcare Needs for Vets 37769 1VVA Introduces Collaboration Between Veterans and Private Sector to Address Healthcare Needs for Vets 37769 2
...SINESS WIRE)--Jun 27, 2007 - The University of,Pit...wing study and,press release, "Scientists Culture ...une 15, 2007, Science Daily: "Researchers at,the U...ccessfully,isolated and cultured human hematopoiet...ing that they have found another important,source ...
...Canada and BASEL, Switzerland, June 27 /CNW/ -,Asp...X: ASV) and,Roche today released preliminary resul...ycophenolate mofetil, MMF) to intravenous,cyclopho...are, for,inducing treatment response in the induct...is., Although response rates were similar in both ...
Other Medicine Technology:Bio-Matrix Scientific's Dr. O'Neill Sees University of Pittsburgh's,Published Study on Culture Blood-Forming Stem Cells from Human Fat,Tissue as Supporting Near Term Benefits of Banking Adipose (Fat),Derived Stem Cells 2Bio-Matrix Scientific's Dr. O'Neill Sees University of Pittsburgh's,Published Study on Culture Blood-Forming Stem Cells from Human Fat,Tissue as Supporting Near Term Benefits of Banking Adipose (Fat),Derived Stem Cells 3Aspreva and Roche Announce Preliminary Results for Phase III Study,Evaluating CellCept in Lupus Nephritis 2Aspreva and Roche Announce Preliminary Results for Phase III Study,Evaluating CellCept in Lupus Nephritis 3Aspreva and Roche Announce Preliminary Results for Phase III Study,Evaluating CellCept in Lupus Nephritis 4Aspreva and Roche Announce Preliminary Results for Phase III Study,Evaluating CellCept in Lupus Nephritis 5Aspreva and Roche Announce Preliminary Results for Phase III Study,Evaluating CellCept in Lupus Nephritis 6Aspreva and Roche Announce Preliminary Results for Phase III Study,Evaluating CellCept in Lupus Nephritis 7Aspreva and Roche Announce Preliminary Results for Phase III Study,Evaluating CellCept in Lupus Nephritis 8